Leading in Innovation, Intelligent Liangjiang New Area
To promote the entrepreneurship and innovation activities of "Intelligent Liangjiang New Area", and select advanced representatives in scientific and technical innovation, the annual news conference on scientific and technical innovation of Intelligent Liangjiang New Area in 2019 jointly undertaken by Publicity Department and Science and Technology Innovation Bureau of Liangjiang New Area and sponsored by Liangjiang New Area Administration Committee comes to a successful conclusion on January 8.
In the event, a number of significant lists were released, including the Innovation and Entrepreneurship Indexes, Key New Technologies and New Products, Science and Technology Innovation Enterprises, and Leading Talents in Science and Technology of Liangjiang New Area in 2019.
Zeng Fanxin, Director of Hemony D&R Center, is appraised as "Leading Talent in Science and Technology of Intelligent Liangjiang New Area in 2019", and Lioresal (Baclofen tablets) is launched as a key new product of Liangjiang New Area in 2019.
Leading Talent in Science and Technology of Intelligent Liangjiang New Area in 2019
◆ Director of D&R Center
◆ Senior engineer
Zeng Fanxin, director of D&R Center of Chongqing Hemony Pharmaceutical Co., Ltd. has jointly undertaken the research and development of 6 Class 1 chemical innovative drugs and has applied for more than 10 international patents, of which, 2 innovative drugs have obtained a contract amount of 388 million euros on international right transfer and a total amount of more than 200 million yuan on domestic right transfer.
In the past 20 years of working and practice in the pharmaceutical industry, it has accumulated rich and advanced experience in research, development and technology management of frontier drugs. It is good at research and development of chemically innovative drugs and generic drugs, and has been active in the frontier of research, development, introduction, cooperative and innovation of new drugs. In recent years, it has been actively committed to introducing new foreign drugs and imported drugs urgently needed in China, bringing new drug choices and treatment opportunities to Chinese patients.
Key New Product of Intelligent Liangjiang New Area in 2019
Lioresal (Baclofen tablets)
Lioresal (Baclofen tablets) is originally developed and launched by Novartis AG, the world's third largest pharmaceutical company.?Hemony acquired the core production technology of the product and the right to exclusively produce and market the product in China in 2018, which achieved a breakthrough in the acquisition of original research products by pharmaceutical enterprises in southwest China, and made Hemony the first pharmaceutical enterprise in Chongqing to own international original product.
In the event, Director Zeng delivers the acceptance speech on behalf of the 10 scientific and technical leading talents who win the award.?He says that it is his honor to be awarded the Top Ten Leading Talents in Science and Technology of Liangjiang New Area".?The appraisal of this award fully reflects the importance attached to science and technology as well as corresponding talents by the Party Working Committee and the Management Committee of Liangjiang New Area.
Director Zeng delivers his acceptance speech
"Meanwhile, I would like to express our thanks on behalf of the 10 scientific and technical colleagues who win the award. Firstly, thank the Party Working Committee and the Management Committee of Liangjiang New Area for their support and help to our scientific and technical talents. Secondly, we would like to thank our company for providing us with a stage to show ourselves. Thirdly, we would like to thank our team, because any scientific and technical achievements are the result of team cooperation."
Team of Hemony D&R Center